In summary, our data demonstrate the potential of using a heat-inducible promoter (HSP70B) to drive NIS expression in MSCs, which allow an increased tumor-specific, temperature- and time-dependent NIS-mediated accumulation of radioiodide in heat-treated tumors. Here, SLC5A5 is linked to neoplasm.